Biomedical Enterprise Program
- Existence: 2002 - 2012
The Biomedical Enterprise Program (BEP) is a joint venture between the Harvard-MIT Division of Health Sciences and Technology and the MIT Sloan School of Management. Planning for the program began in 2001 and the first students entered in September 2002. The intention of the double master’s program is to educate leaders for the future of biomedical enterprises. According to the MIT Reports to the President, 2001-2002, the “mission of BEP is to equip its graduates to lead the commercialization of new technologies for the innovative diagnosis, prevention, and treatment of human disease in new and established companies.” Frank R. Landsberger served as executive director from the program’s inception until 2003. In 2003 coordination of the program was taken over by Marsha Warren. In 2004, Dr. Richard Cohen and Dr. Ernst Berndt became co-directors of the program. The program was terminated in November 2012.
Found in 1 Collection or Record:
The collection consists of the Biomedical Enterprise Program steering committee minutes, Health Sciences & Technology (HST) Advisory Council minutes, background materials and published materials.